EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Modeling viral shedding and symptom outcomes in oseltamivir-treated experimental influenza infection

Yasuhisa Fujita, Marwa Akao, Daiki Tatematsu, Shingo Iwami, Naotoshi Nakamura, Shoya Iwanami iD

PLOS One · 2026

DOI: 10.1371/journal.pone.0342676 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Yasuhisa Fujita und 5 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Biology Laboratory (iBLab), Division of Natural Science, Graduate School of Science, Nagoya University, Aichi, Japan. Hauptthemen laut MEDLINE: Oseltamivir, Virus Shedding, Antiviral Agents, Influenza, Human. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Influenza remains a global public health concern, and although the antiviral drug oseltamivir is widely used to treat infections, questions regarding its actual antiviral efficacy and clinical benefits remain. Here, we evaluated the effects of oseltamivir on viral shedding dynamics in the context of experimental influenza infection. We analyzed individual participant data, including viral load, time to symptom alleviation, and laboratory test measurements, obtained from three publicly available clinical trials involving experimental infections with influenza A and B viruses. We applied mathematical modeling and estimated parameters using a nonlinear mixed-effects model to capture viral infection dynamics. Our analysis revealed that, compared with placebo groups, the oseltamivir-treated groups tended to have lower values in terms of viral load area under the curve, duration of infection, peak viral titer, and time to peak; however, most of these differences were not significant; and no dose-dependent effects were observed. Moreover, there was no significant correlation between time to symptom alleviation and viral load. Some laboratory test parameters showed opposing correlations with symptom-related and viral load-related outcomes. These findings are consistent with distinct mechanisms underlying the symptom-alleviating effects of oseltamivir and its antiviral activity. Our findings suggest that the availability of individual-level data for public use is essential because it enables the evaluation of mechanisms in clinical trials and the development of more appropriate outcome measures.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OseltamivirVirus SheddingAntiviral AgentsInfluenza, HumanHumansViral LoadInfluenza A virusTreatment OutcomeInfluenza B virusModels, Biological

Substanzen

OseltamivirAntiviral Agents

Autor:innen und Institutionen

  • Interdisciplinary Biology Laboratory (iBLab), Division of Natural Science, Graduate School of Science, Nagoya University, Aichi, Japan.
  • Institute of Mathematics for Industry, Kyushu University, Fukuoka, Japan.
  • Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto, Japan.
  • Interdisciplinary Theoretical and Mathematical Sciences Program (iTHEMS), RIKEN, Saitama, Japan.
  • NEXT-Ganken Program, Japanese Foundation for Cancer Research (JFCR), Tokyo, Japan.
  • International Research Center for Neurointelligence, The University of Tokyo Institutes for Advanced Study, The University of Tokyo, Tokyo, Japan.

ORCID-Profile: Shoya Iwanami

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Fujita, Y., Akao, M., Tatematsu, D., Iwami, S., Nakamura, N., & Iwanami, S. (2026). Modeling viral shedding and symptom outcomes in oseltamivir-treated experimental influenza infection. PLOS One. https://doi.org/10.1371/journal.pone.0342676

Vancouver

Fujita Y, Akao M, Tatematsu D, Iwami S, Nakamura N, Iwanami S. Modeling viral shedding and symptom outcomes in oseltamivir-treated experimental influenza infection. PLOS One. 2026. doi:10.1371/journal.pone.0342676

BibTeX
@article{Fujita2026,
  author = {Fujita, Yasuhisa and Akao, Marwa and Tatematsu, Daiki and Iwami, Shingo and Nakamura, Naotoshi and Iwanami, Shoya},
  title = {Modeling viral shedding and symptom outcomes in oseltamivir-treated experimental influenza infection},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0342676}
}
Kostenlos starten →